Medexus Pharmaceuticals Inc. (TSX:MDP)

Medexus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	9.33	23.97	5.26	13.07	10.02	18.7
Cash & Short-Term Investments	9.33	23.97	5.26	13.07	10.02	18.7
Cash Growth	10.39%	356.19%	-59.79%	30.45%	-46.44%	257.42%
Accounts Receivable	12.22	13.17	23.87	21.97	13.39	18.4
Other Receivables	0.15	0.14	0.16	0.41	1.02	0.43
Receivables	12.36	13.31	24.03	22.38	14.41	18.83
Inventory	35.4	39.82	36.72	22.85	21.35	14.67
Prepaid Expenses	7.13	3.1	4.19	12.38	2.06	4.71
Other Current Assets	-	0.38	2.3	2.3	1.28	1.67
Total Current Assets	64.22	80.57	72.5	72.97	49.11	58.57
Property, Plant & Equipment	0.57	0.69	0.78	0.9	1.22	0.8
Goodwill	10.24	10	10.28	10.28	10.69	10.65
Other Intangible Assets	69.52	71.6	64.14	70.37	76.57	76.36
Long-Term Deferred Tax Assets	9.24	8.98	8.04	6.81	-	-
Other Long-Term Assets	-	-	-	-	1.64	2.13
Total Assets	153.79	171.84	155.73	161.33	139.23	148.51
Accounts Payable	39.69	5.73	7.75	10.16	12.05	14.86
Accrued Expenses	-	35.29	35.48	23.26	17.13	12.47
Current Portion of Long-Term Debt	21.5	36.79	15.74	42.71	15.05	10.57
Current Portion of Leases	0.23	0.19	-	-	-	-
Current Income Taxes Payable	1.72	1.37	1.32	1.18	0.03	0.51
Other Current Liabilities	15.75	17.94	5.94	6.19	3.86	1.53
Total Current Liabilities	78.89	97.31	66.23	83.5	48.11	39.94
Long-Term Debt	-	-	33.61	26.78	39.03	34.09
Long-Term Leases	0.16	0.2	0.54	0.6	0.78	0.21
Long-Term Deferred Tax Liabilities	-	-	-	-	1.52	2.65
Other Long-Term Liabilities	21.78	22.19	25.03	28.01	31.99	53.61
Total Liabilities	100.83	119.7	125.41	138.88	121.43	130.5
Common Stock	96.1	96.1	76.39	69.01	68.69	66.69
Additional Paid-In Capital	12.18	12.01	12.01	11.31	10.38	9.5
Retained Earnings	-61.48	-62	-64.24	-64.03	-65.25	-62.37
Comprehensive Income & Other	6.16	6.03	6.17	6.16	3.97	4.2
Shareholders' Equity	52.96	52.14	30.32	22.45	17.79	18.02
Total Liabilities & Equity	153.79	171.84	155.73	161.33	139.23	148.51
Total Debt	21.9	37.18	49.9	70.08	54.86	44.87
Net Cash (Debt)	-12.56	-13.21	-44.64	-57.01	-44.84	-26.17
Net Cash Per Share	-0.44	-0.50	-2.00	-2.78	-2.26	-1.72
Filing Date Shares Outstanding	32.26	32.26	24.46	20.25	19.95	19.17
Total Common Shares Outstanding	32.26	32.26	24.46	20.18	19.95	19.17
Working Capital	-14.67	-16.74	6.27	-10.53	1	18.63
Book Value Per Share	1.64	1.62	1.24	1.11	0.89	0.94
Tangible Book Value	-26.8	-29.46	-44.09	-58.21	-69.46	-69
Tangible Book Value Per Share	-0.83	-0.91	-1.80	-2.88	-3.48	-3.60
Machinery	-	1.26	1.12	1.07	1.06	0.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.